This suggests that the TNF and STAT3 genes are likely to be crucial in the development of CY-induced immunodeficiency, and targeting them could be a potential therapeutic approach for GAC in treating immunodeficiency. The gene discussed is STAT3; the disease is immunodeficiency disease.